Global Isosorbide Mononitrate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Isosorbide Mononitrate Market Research Report 2024
Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris and acts by dilating the blood vessels so as to reduce the blood pressure.
According to Mr Accuracy reports new survey, global Isosorbide Mononitrate market is projected to reach US$ 281.2 million in 2029, increasing from US$ 185 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Isosorbide Mononitrate market research.
Key manufacturers engaged in the Isosorbide Mononitrate industry include Teva, Merck, Nesher Pharmaceuticals, Taj pharmaceutical, AMRI, Intas Pharmaceuticals, Sandoz, Globus Remedies and Intas Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Isosorbide Mononitrate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Isosorbide Mononitrate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Isosorbide Mononitrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Teva
Merck
Nesher Pharmaceuticals
Taj pharmaceutical
AMRI
Intas Pharmaceuticals
Sandoz
Globus Remedies
Intas Pharmaceuticals
Shandong Fangming Pharmaceutical Group
ReYoung Pharmaceutical
Segment by Type
10 mg Tablet
20 mg Tablet
Treatment of Angina Pectoris
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Isosorbide Mononitrate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Isosorbide Mononitrate market is projected to reach US$ 281.2 million in 2029, increasing from US$ 185 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Isosorbide Mononitrate market research.
Key manufacturers engaged in the Isosorbide Mononitrate industry include Teva, Merck, Nesher Pharmaceuticals, Taj pharmaceutical, AMRI, Intas Pharmaceuticals, Sandoz, Globus Remedies and Intas Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Isosorbide Mononitrate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Isosorbide Mononitrate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Isosorbide Mononitrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Merck
Nesher Pharmaceuticals
Taj pharmaceutical
AMRI
Intas Pharmaceuticals
Sandoz
Globus Remedies
Intas Pharmaceuticals
Shandong Fangming Pharmaceutical Group
ReYoung Pharmaceutical
Segment by Type
10 mg Tablet
20 mg Tablet
Segment by Application
Treatment of Angina Pectoris
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Isosorbide Mononitrate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source